Site gratuit créé sur
➢ VIRUS DE LA GRIPPE SEGMENTÉS EN 9 ET 10 STABILISÉS EN TANT QUE PLATEFORME DE VACCIN ET PROCÉDÉS DE FABRICATION ET D'UTILISATION DE CEUX-CI
☆ Inventeur(s): HEATON NICHOLAS, HARDING ALFRED, Duke University Medical Center, Mol. Genetics/Microbio., 213 Research Drive, 426 CARL Building, Box 3054, Durham, NC27710 [US]; HAAS GRIFFIN, 50 East 98th Street Room #10E-4, New-York, NY 10029 [US]; GIRTON ALANSON, 5055 Jefferson Pike, Frederick, MD 21703 [US]
Demandeur(s): DUKE UNIVERSITY, 2812, Erwin road, Durham, NC27705 [USA]
Classification internationale (CIB): A61K39/145; A61P31/16; A61P37/04; C12N15/09; C12N7/00; C12N7/01
Classification coopérative (CPC): A61K39/0011 (EP); A61K39/145 (EP, US); A61K9/0043 (US); A61P31/16 (EP, US); A61P37/04 (EP); C12N15/09 (US); C12N7/00 (EP); A61K2039/5156 (EP); A61K2039/5252 (US); A61K2039/5254 (EP); A61K2039/543 (EP); C12N2760/16111 (EP); C12N2760/16121 (EP); C12N2760/16122 (EP); C12N2760/16132 (EP); C12N2760/16134 (EP); C12N2760/16143 (EP)
N° de la demande: WO2020US17303 20200207
Numéro(s) de priorité: US201962802385P 20190207
Publication(s) associée(s): US2023060867 (A1)
Date de priorité: 07.02.2019
Lien vers Espacenet, base Worldwide
➢ VECTEUR VIRAL DE L'INTERFÉRON GAMMA HUMAIN ET SON UTILISATION
☆ Inventeur(s): HUANG WENLIN, TIAN SHUO, ZHOU XIAOHONG [China]
Demandeur(s): GUANGZHOU DOUBLLE BIOPRODUCT CO., LTD., 8th Floor Building B1, 11 Kaiyuan Avenue Guangzhou Guangdong [China]
Classification internationale (CIB): C12N 15/861 C12N 15/62 A61K 48/00 A61K 38/21 A61P 35/00 A61P 31/12 A61P 31/14 A61P 31/20 A61P 1/16 A61P 31/22 A61P 1/02
Classification coopérative (CPC): C12N 15/86 C07K 14/57 A61K 48/005 A61K 48/0008 A61K 38/217 A61P 35/00 A61P 31/12 A61P 31/14 A61P 31/20 A61P 1/16 A61P 31/22 A61P 1/02 C07K 2319/02 C12N 2710/10043 C12N 2800/22 C12N 2800/107
N° de la demande: CN112980883
Numéro(s) de priorité: CN112980883
Publication(s) associée(s): CN112980883 (B)
Date de priorité: 03.03.2021
Lien vers Espacenet, base Worldwide
➢ VECTEURS DE VIRUS À ARN PORTEURS DE DAI ET DE RIPK3
☆ Inventeur(s): SIDDHARTH BALACHANDRAN, ROSHAN THAPA, Philadelphia, PA, [US]
Demandeur(s): Institute For Cancer Research d/b/a The Research Institute Of Fox Chase Cancer Center, Philadelphia, PA, [USA]
Classification internationale (CIB): A61K39/39; A61P37/04; C07K14/47; C12N15/86; C12N9/12
Classification coopérative (CPC): A61K39/39 (EP, US); A61P37/04 (EP, US); C07K14/47 (US); C07K14/4705 (US); C12N15/86 (EP, US); C12N9/12 (EP, US); C12Y207/11001 (EP, US); A61K2039/585 (EP, US); C12N2760/16121 (EP, US); C12N2760/16132 (EP, US); C12N2760/16143 (EP, US)
N° de la demande: US202217723119 20220418
Numéro(s) de priorité: US201662359465P 20160707 ; WO2017US40719 20170705 ; US201916315420 20190104 ; US202217723119 20220418
Publication(s) associée(s): EP3481419 (A1) EP3481419 (A4) EP3481419 (B1) US11332756 (B2) US2019211359 (A1) WO2018009541 (A1)
Date de priorité: 07.07.2016
Lien vers Espacenet, base Worldwide
➢ VIRUS INFLUENZA DÉFICIENT QUANT À LA RÉPLICATION POUR L'EXPRESSION DE SÉQUENCES HÉTÉROLOGUES
☆ Inventeur(s): WOLSCHEK MARKUS, Vienna [AT]; EGOROV ANDREJ, Vienna [AT]; BERGMANN MICHAEL, Klosterneuburg [AT]; MUSTER THOMAS, Vienna [AT]; KITTEL CHRISTIAN, Vienna [AT]
Demandeur(s): AVIR GREEN HILLS BIOTECHNOLOGY RESEARCH DEVELOPMENT TRADE AG, WIEN [Austria]
Classification internationale (CIB): A61K39/00; A61K39/145; C07K14/11; C12N15/62; C12N15/86
Classification coopérative (CPC): C07K14/005 (EP, US); C12N15/86 (EP, US); C12N7/00 (EP, US); A61K2039/525 (EP, US); A61K2039/5256 (EP, US); A61K39/00 (EP, US); C12N2760/16132 (EP, US); C12N2760/16143 (EP, US); C12N2760/16243 (EP, US)
N° de la demande: EP20080774337 20080626
Numéro(s) de priorité: US20070946644P 20070627 ; EP20070450176 20071005 ; EP20080774337 20080626 ; WO2008EP58154 20080626
Publication(s) associée(s): AU2008274360 (A1) CA2690317 (A1) CN101796190 (A) EA018174 (B1) EA201000077 (A1) EP2048237 (A1) NZ582099 (A) US2010136052 (A1) US2014045245 (A1) US9187732 (B2) WO2009007244 (A2) WO2009007244 (A3)
Date de priorité: 27.06.2007
Lien vers Espacenet, base Worldwide
➢ INTERFÉRON INDUISANT DES VIRUS ATTENUÉS MIS AU POINT PAR GÉNIE GÉNÉTIQUE
☆ Inventeur(s): EGOROV ANDREJ [AT]; MUSTER THOMAS [AT]; GARCIA-SASTRE ADOLFO; PALESE PETER
Demandeur(s): MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK; EGOROV, ANDREJ; MUSTER, THOMAS, One Gustave Levy Place, New-York, NY 10029-6574 [USA]
Classification internationale (CIB): A61K35/76; A61K39/12; A61K39/145; A61K39/295; A61P31/16; C07K14/11; C12N15/09; C12N15/86; C12N7/00; C12N7/01; C12N7/04; (IPC1-7): A61K39/145; A61K39/295; C12N15/86; C12N7/01; C12N7/04
Classification coopérative (CPC): A61K39/12 (EP, US); A61K39/145 (EP, US); A61P31/16 (EP); C07K14/005 (EP, US); C12N15/86 (EP, US); C12N7/00 (EP, US); A61K2039/525 (EP, US); A61K2039/5254 (EP, US); A61K2039/5256 (EP, US); C12N2760/16121 (EP, US); C12N2760/16122 (EP, US); C12N2760/16132 (EP, US); C12N2760/16134 (EP, US); C12N2760/16161 (EP, US); C12N2830/002 (EP, US); Y02A50/30 (EP, US)
N° de la demande: WO1999US13139 19990611
Numéro(s) de priorité: US19980089103P 19980612
Publication(s) associée(s): AT384126 (T) AU4434199 (A) AU748416 (B2) CA2334857 (A1) CA2334857 (C) DE69937999 (T2) DK1098961 (T3) EP1098961 (A1) EP1098961 (A4) EP1098961 (B1) ES2301241 (T3) JP2002517230 (A) JP4441595 (B2) PT1098961 (E) US2003157131 (A1) US6468544 (B1) US6866853 (B2) ZA200007403 (B
Date de priorité: 12.06.1998
Lien vers Espacenet, base Worldwide
➢ PROCÉDÉ POUR LA SÉPARATION DE COMPOSITIONS VIRALES COMPRENANT L'APPAUVRISSEMENT ET LA PURIFICATION DE CES DERNIÈRES
☆ Inventeur(s): WOLFF MICHAEL, Am Weidenring 3d, 39175 Biederitz [Deutchland]; PIELER MICHAEL MARTIN, Breiter Weg 256, 39104 Magdebourg [Deutchland]; REICHL UDO, An der Elbe 5, 39104 Magdeburg [Deutchland]; MARICHAL-GALLARDO PAVEL, Berliner Chaussee 71, 39114 Maagdeburg [Deutchland]
Demandeur(s): MAX PLANCK GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V; Hofgartenstrasse 8, 80539 München, [Deutchland]
Classification internationale (CIB): C12N7/00; C12N7/02
Classification coopérative (CPC): C12N7/00 (EP, US); C12N2760/16132 (US); C12N2760/16151 (EP, US); C12N2760/16152 (US)
N° de la demande: EP20160775616 20160926
Numéro(s) de priorité: EP20150193102 20151105 ; EP20160174958 20160617 ; WO2016EP72809 20160926
Publication(s) associée(s): US2019085300 (A1) WO2017076553 (A1)
Date de priorité: 05.11.2015
Lien vers Espacenet, base Worldwide
➢ CHIMÈRE DE VIRUS PATHOGÈNE ÉMERGENT, MÉDICAMENT LA CONTENANT ET UTILISATION EN THÉRAPIE ANTIVIRALE
☆ Inventeur(s): MILLET DAVID, 12, rue des cartelets, 01000 Bourg en Bresse [France]
Demandeur(s): MILLET DAVID, 01000 Bourg en Bresse [France]
Classification internationale (CIB): A61K35/76; A61K39/12; A61K39/145; A61K48/00; A61P31/12; C12N7/01; C12N7/04; G01N33/53; (IPC1-7): A61K39/12; A61K39/145; A61K48/00; A61P31/12; C12N7/01; C12N7/04; G01N33/53
Classification coopérative (CPC): A61K39/12 (EP); A61K39/145 (EP); A61P31/12 (EP); C12N7/00 (EP); C12N2760/16132 (EP); C12N2760/16134 (EP); C12N2760/16161 (EP)
N° de la demande: FR20040001364 20040211
Numéro(s) de priorité: FR20040001364 20040211
Publication(s) associée(s): FR2866031 (B1)
Date de priorité: 11.02.2004
Lien vers Espacenet, base Worldwide
➢ MOLÉCULES D'ACIDE NUCLÉIQUE ET PEPTIDES À DOUBLE FONCTION AYANT UNE ACTIVITÉ ANTIVIRALE ET UNE ACTIVITÉ D'ACHEMINEMENT ET COMPOSITIONS ET PROCÉDÉS CORRESPONDANTS
☆ Inventeur(s): ZHAO HANJUN, 601, Number 27, Chang Hong Fang, Number 11 Gui Lin Xi Jie, Shanghai 200234 [China]; TO KAI WANG KELVIN Flat B, 16th Floor, Bel-Air Number 8, Bel-Air on the Peak, 8 Bel-Air Peak Avenue, Pokfulam, Hong Kong [China]; YUEN KWOK YUNG, Flat C, 19th Floor, Block 20, Baguio Villa, 555 Victoria Road, Hong Kong [China]
Demandeur(s): UNIVERSITE DE HONG KONG, Pokfulam Road, Hong Kong [China]
Classification internationale (CIB): A61K35/76; A61K39/145; A61P31/16; C07K14/155; C12N15/44; C12N15/49; C12N15/62; C12N15/86
Classification coopérative (CPC): A61K39/12 (EP); A61K39/145 (US); A61K9/007 (US); A61K9/0073 (US); A61P31/16 (EP, US); C07K14/005 (EP, US); C12N15/62 (EP, US); C12N15/86 (US); A61K2039/5256 (US); A61K2039/54 (US); A61K2039/545 (US); A61K2039/572 (EP, US); A61K38/00 (EP); C12N2740/16022 (US); C12N2740/16032 (US); C12N2740/16043 (US); C12N2760/16121 (EP); C12N2760/16122 (EP, US); C12N2760/16132 (EP); C12N2760/16134 (EP, US); C12N2760/16143 (US)
N° de la demande: EP20190792753 20190426
Numéro(s) de priorité: US201862663076P 20180426 ; US201862668872P 20180509 ; WO2019CN84612 20190426
Publication(s) associée(s): EP3784789 (A4) CN112424367 (A) US2021238629 (A1) WO2019206285 (A1)
Date de priorité: 26.04.2018
Lien vers Espacenet, base Worldwide
➢ PROTECTION ANTIVIRALE PRODUITE À L'AIDE DE VIRUS CONTENANT DES SEGMENTS DE GÉNOME DÉFECTUEUX
☆ Inventeur(s): DIMMOCK NIGEL [GB]; EASTON ANDREW [US]
Demandeur(s): UNIVERSITE DE WARWICK [GB]
Classification internationale (CIB): A61K35/76; C12N7/04
Classification coopérative (CPC): A61K35/76 (EP, US); A61P31/12 (EP); A61P31/14 (EP); A61P31/16 (EP); C12N7/00 (EP, US); C12N2760/16132 (EP, US); C12N2760/16162 (EP, US)
N° de la demande: CA20092746495 20091208
Numéro(s) de priorité: GB20080022672 20081212 ; WO2009GB51666 20091208
Publication(s) associée(s): CA2746495 (C) AU2009326204 (A1) AU2009326204 (B2) CN102256611 (A) CN102256611 (B) DK2355834 (T3) EP2355834 (A1) EP2355834 (B1) ES2423193 (T3) IN2819KON2011 (A) PL2355834 (T3) US2011243896 (A1) US8691215 (B2) WO2010067109 (A1)
Date de priorité: 12.12.2008
Lien vers Espacenet, base Worldwide
➢ VIRIONS AAV PRÉSENTANT UNE IMMUNORÉACTIVITÉ RÉDUITE ET LEUR UTILISATION
☆ Inventeur(s): ARBETMAN ALEJANDRA ELENA, 1261 8th Avenue, 202 San Francisco, California 94122 [USA]; COLOSI PETER, 1522 Court Street, Alameda, California 94501 [USA]; LOCHRIE MICHAEL A., 3374 Creekview Court, Hayward, California 94541 [USA]; SUROSKY RICHARD T., 5104 Shafter Avenue, Oakland, California 94618 [USA]
Demandeur(s): AVIGEN, INC., 1301 Harbor Bay parkway, Alameda CA 94502 [USA]
Classification internationale (CIB): C07K1/00; C07K14/00; C07K14/015; C07K17/00; C12N15/00; C12N15/09; C12N15/63; C12N15/70; C12N15/74; C12N15/864; A61K
Classification coopérative (CPC): A61K38/4846 (EP, US); A61K48/00 (EP, US); A61K48/0058 (US); A61K48/0066 (US); A61K48/0075 (US); A61P11/00 (EP); A61P13/12 (EP); A61P19/06 (EP); A61P21/04 (EP); A61P25/16 (EP); A61P29/00 (EP); A61P3/00 (EP); A61P3/06 (EP); A61P3/08 (EP); A61P3/10 (EP); A61P35/00 (EP); A61P37/02 (EP); A61P37/04 (EP); A61P7/02 (EP); A61P7/04 (EP); A61P7/06 (EP); A61P9/04 (EP); A61P9/10 (EP); C07K14/005 (EP, US); C12N15/86 (EP, US); C12N7/00 (EP, US); C12Y304/21022 (EP, US); C12N2750/14121 (EP, US); C12N2750/14122 (EP, US); C12N2750/14143 (EP, US); C12N2750/14162 (EP, US); C12N2830/008 (EP, US); C12N2830/85 (EP, US)
N° de la demande: DK20040755800T 20040621
Numéro(s) de priorité: US20030480395P 20030619 ; US20040567310P 20040430 ; US20040576501P 20040603 ; WO2004US19884 20040621
Publication(s) associée(s): CY1117575 (T1) CY1119222 (T1) CY1119241 (T1) CY1119279 (T1) DK2357189 (T3) DK2657247 (T3) DK2657248 (T3) DK3235827 (T3) EP1633772 (A2) EP1633772 (A4) EP1633772 (B1) EP2357189 (A2) EP2357189 (A3) EP2357189 (B1) EP2657247 (A1) EP2657247 (B1) EP2657248 (A1) EP2657248 (B1) EP3235827 (A2) EP3235827 (A3) EP3235827 (B1) ES2563064 (T3) ES2627913 (T3) ES2629087 (T3) ES2629380 (T3) ES2862206 (T3) HUE029556 (T2) HUE034546 (T2) HUE034597 (T2) HUE034785 (T2) HUE054046 (T2) JP2007524386 (A) JP2010273690 (A) JP2014057579 (A) JP2016084362 (A) JP2018029614 (A) JP2020096642 (A) JP5551029 (B2) JP6759177 (B2) PL1633772 (T3) PL2357189 (T3) PL2657247 (T3) PL2657248 (T3) PL3235827 (T3) PT1633772 (E) PT2357189 (T) PT2657247 (T) PT2657248 (T) PT3235827 (T) SI1633772 (T1) SI2357189 (T1) SI2657247 (T1) SI2657248 (T1) SI3235827 (T1) US11083800 (B2) US2006051333 (A1) US2008008690 (A1) US2017232117 (A1) US2018280540 (A1) US2019314526 (A1) US2022016264 (A1) US7259151 (B2) US9506083 (B2) WO2004112727 (A2) WO2004112727 (A3)
Date de priorité: 19.06.2003
Lien vers Espacenet, base Worldwide
|